Author: Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 130
Book Description
Prescription Drug Marketing Act: Nebraska-New York
Author: Prescription Drug Marketing Act
Author: Prescription Drug Marketing Act
Author: Prescription Drug Marketing Act: Iowa-Maryland
Author: Statutes, Rules and Regulations Relating to Pharmacy, Drugs: Adulterated Or Misbranded, Emergency Box Drug Act, Mail Service Prescription Drug Act, Poisons, Nebraska Drug Product Selection Act, Wholesale Drug Distributor Licensing Act
Author: Nebraska. Bureau of Examining BoardsPublisher:
ISBN:
Category :
Languages : en
Pages : 51
Book Description
Prescription Drug Marketing Act of 1987
Author: United States. Congress. Senate. Committee on FinancePublisher:
ISBN:
Category : Business ethics
Languages : en
Pages : 20
Book Description
Pain Management and the Opioid Epidemic
Author: National Academies of Sciences, Engineering, and MedicinePublisher: National Academies Press
ISBN: 0309459575
Category : Medical
Languages : en
Pages : 483
Book Description
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Handbook of Biosurveillance
Author: Michael M. WagnerPublisher: Elsevier
ISBN: 0080459994
Category : Science
Languages : en
Pages : 621
Book Description
Provides a coherent and comprehensive account of the theory and practice of real-time human disease outbreak detection, explicitly recognizing the revolution in practices of infection control and public health surveillance. - Reviews the current mathematical, statistical, and computer science systems for early detection of disease outbreaks - Provides extensive coverage of existing surveillance data - Discusses experimental methods for data measurement and evaluation - Addresses engineering and practical implementation of effective early detection systems - Includes real case studies
Food and Drug Law Journal
Author: Drug and Medical Device Product Liability Deskbook
Author: James BeckPublisher: Law Journal Press
ISBN: 9781588521217
Category : Actions and defenses
Languages : en
Pages : 982
Book Description
This timely guide covers all aspects of litigation involving drugs, medical devices, vaccines and other FDA-regulated prescription products.